The present study was designed to observe the oestrus responses in the indigenous ewe induced by cloprostenol sodium manufactured by two different companies (Ovuprost®, BOMAC, Newzealandand Prostenol®, Techno, Bangladesh). Twelve local ewes were divided into 3 groups (n= 8). The ewes in Group I and II were induced by intramuscular injection of 100 μg (0.4 ml) of cloprostenol sodium (Ovuprost® and Prostenol®), respectively. The 2nd injection in each group was given at 9 days apart. The ewes in Group III were kept as control for observing natural oestrus characteristics and comparing the responses with induced oestrus. Hundred and 75% ewes showed oestrus following 2nd injection of Ovuprost® and Prostenol®, respectively. The average time of onset of oestrus following 1st and 2nd injection of Ovuprost® and Prostenol® were 50.5 ± 3.5 vs 48.0 ± 0.0 h and 49.9 ± 1.9 vs 49.5 ± 1.7 h, respectively. There was no significant difference between the two types of cloprostenol sodium group on the onset of oestrus. The average duration of oestrus was 27.5 ± 0.7 vs 27.5 ± 0.0 h and 25.9 ± 3.3 vs 24.2 ± 0.3 h in Ovuprost® and Prostenol® treated ewes, respectively. For natural oestrus, the duration of oestrus was 25.2 ± 3.3 h. There was no significant difference among the cloprostenol sodium produced by two different companies and natural oestrous ewes on the duration of oestrus. The higher percentages of cornified cells were present in induced oestrus (90 and 85%) compared with natural oestrus (80%), although there was no significant difference among them. The pregnancy rates were 75, 66.7 and 100% in Ovuprost®, Prostenol® and natural oestrous ewes, respectively. The above results indicate the suitability of using cloprostenol sodium for synchronization of oestrus in indigenous ewes in Bangladesh.

The present study was conducted for the production of transgenic cloned cows by somatic cell nuclear transfer (SCNT) that secrete human prourokinase into milk. To establish an efficient production system for bovine transgenic SCNT embryos, the offset was examined of various conditions of donor cells including cell type, size, and passage number on the developmental competence of transgenic SCNT embryos. An expression plasmid far human prourokinase (pbeta-ProU) was constructed by inserting a bovine beta-casein promoter, a green fluorescent protein (GFP) marker gene, and a human prourokinase target gene into a pcDNA3 plasmid. Three types of bovine somatic cells including two adult cells (cumulus cells and ear fibroblasts) and fetal fibroblasts were prepared and transfected using a lipid-meidated method. In Experiment 1, developmental competence and rates of GFP expression in bovine transgenic SCNT embryos reconstructed with cumulus cells were significantly higher than those from fetal and ear fibroblasts. In Experiment 2, the effect of cellular senescence in early (2 to 4) and late (8 to 12) passages was investigated. No significant differences in the development of transgenic SCNT embryos were observed. In Experient 3, different sizes of GFP-expressing transfected cumulus cells [large (>30 ) or small cell (<30 )] were used for SCNT. A significant improvement in embryo development and GFP expression was observed when small cumulus cells were used for SCNT. Taken together, these results demonstrate that (1) adult somatic cells could serve as donor cells in transgenic SCNT embryo production and cumulus cells with small size at early passage were the optimal cell type, and (2) transgenic SCNT embryos derived from adult somatic cells have embryonic development potential.

The present study aimed at determining the effective dose of Folltropin, a follicle timulating hormone (FSH), on superovulation in indigenous cows of Bangladesh. Fifteen regularly cycling 5～7 years old dry cows, weighing 200～250 kg with 2.5～3.0 body condition scores (BCS) were divided into three groups (n＝5). Individual groups were superovulated with 100, 200 or 300 mg of Folltropin per animal. The superovulation treatment was initiated at Day 10 or Day 11 of the estrous cycle (Day 0＝day of estrus). Alfaprostol (6 mg) was injected to each cow 72 h after the initiation of superovulation treatment to induce eestrus. After confirming standing estrus, the cows were inseminated 2～3 times, 12 h apart, depending on the duration of estrus. At Day 6 or Day 7, individual horns of the uterus were flushed with 150～200 of phosphate buffered saline supplemented with BSA (0.2％), penicillin (100 IU／) and streptomycin (100 ／) using a two-way foley catheter. The embryos were concentrated, removing the excess medium through an embryo filter, and identified under a stereomicroscope. The identified embryos were collected, washed four times, evaluated and graded as excellent, good, fair or poor. The excellent, good and fair embryos were considered as transferable quality embryos. The mean (range). numbers of embryos collected vs. transferable quality embryos far 100, 200 and 300 mg of Folltropin were 4.5 (1～10) vs. 3.5 (1～8); 2.5 (1～4) vs. 1 (0～2) and 0.0 (0～0) vs. 0.0 (0～0), respectively, Folltropin at a dose of 100 or 200 mg produced suitable ovarian stimulation for superovulation in indigenous zebu cows of Bangladesh. A dose of 300 mg or more Folltropin consistently caused preovulatory corpora lutea formation in the ovaries and resulted in zero embryo recovery.